Biomarin Pharmaceutical (BMRN) Q3 2017 Earnings

2AugConfirmed
Q4 2016
Q1 2017
Q2 2017
Q3 2017
-0.53
-0.38
-0.24
-0.09

Details

Expected EPS
-0.23
Actual EPS
-0.21
Surprise EPS
0.02
Surprise Percent
+8.7%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of -0.21 per share for Q3 2017.

0 Comments

Share your thoughts